FTC sues significant pharmacy benefit managers around insulin price ranges The company introduced action in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the listing cost of existence-preserving insulin prescription drugs. This program aligns with Those people efforts, the ONC explained. https://daveshotchickencalories27271.blog2news.com/31232556/details-fiction-and-healthcare-news